These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23674768)
41. Diffusion-weighted MRI of malignant pleural mesothelioma: preliminary assessment of apparent diffusion coefficient in histologic subtypes. Gill RR; Umeoka S; Mamata H; Tilleman TR; Stanwell P; Woodhams R; Padera RF; Sugarbaker DJ; Hatabu H AJR Am J Roentgenol; 2010 Aug; 195(2):W125-30. PubMed ID: 20651171 [TBL] [Abstract][Full Text] [Related]
42. Role of apparent diffusion coefficient values and diffusion-weighted magnetic resonance imaging in differentiation between benign and malignant thyroid nodules. Mutlu H; Sivrioglu AK; Sonmez G; Velioglu M; Sildiroglu HO; Basekim CC; Kizilkaya E Clin Imaging; 2012; 36(1):1-7. PubMed ID: 22226435 [TBL] [Abstract][Full Text] [Related]
43. Renal lesions: characterization with diffusion-weighted imaging versus contrast-enhanced MR imaging. Taouli B; Thakur RK; Mannelli L; Babb JS; Kim S; Hecht EM; Lee VS; Israel GM Radiology; 2009 May; 251(2):398-407. PubMed ID: 19276322 [TBL] [Abstract][Full Text] [Related]
44. Staging hepatic fibrosis: comparison of gadoxetate disodium-enhanced and diffusion-weighted MR imaging--preliminary observations. Watanabe H; Kanematsu M; Goshima S; Kondo H; Onozuka M; Moriyama N; Bae KT Radiology; 2011 Apr; 259(1):142-50. PubMed ID: 21248234 [TBL] [Abstract][Full Text] [Related]
45. Diffusion-weighted MR imaging of early-stage Creutzfeldt-Jakob disease: typical and atypical manifestations. Ukisu R; Kushihashi T; Tanaka E; Baba M; Usui N; Fujisawa H; Takenaka H Radiographics; 2006 Oct; 26 Suppl 1():S191-204. PubMed ID: 17050516 [TBL] [Abstract][Full Text] [Related]
46. Subarachnoid hemorrhage in the subacute stage: elevated apparent diffusion coefficient in normal-appearing brain tissue after treatment. Liu Y; Soppi V; Mustonen T; Könönen M; Koivisto T; Koskela A; Rinne J; Vanninen RL Radiology; 2007 Feb; 242(2):518-25. PubMed ID: 17179395 [TBL] [Abstract][Full Text] [Related]
47. Diffusion-weighted imaging in pediatric body magnetic resonance imaging. Chavhan GB; Caro-Dominguez P Pediatr Radiol; 2016 May; 46(6):847-57. PubMed ID: 27229502 [TBL] [Abstract][Full Text] [Related]
48. Prostate cancer: identification with combined diffusion-weighted MR imaging and 3D 1H MR spectroscopic imaging--correlation with pathologic findings. Mazaheri Y; Shukla-Dave A; Hricak H; Fine SW; Zhang J; Inurrigarro G; Moskowitz CS; Ishill NM; Reuter VE; Touijer K; Zakian KL; Koutcher JA Radiology; 2008 Feb; 246(2):480-8. PubMed ID: 18227542 [TBL] [Abstract][Full Text] [Related]
49. Diffusion-weighted MR imaging of female pelvic tumors: a pictorial review. Whittaker CS; Coady A; Culver L; Rustin G; Padwick M; Padhani AR Radiographics; 2009; 29(3):759-74; discussion 774-8. PubMed ID: 19448114 [TBL] [Abstract][Full Text] [Related]
50. Diagnostic value of apparent diffusion coefficients to differentiate benign from malignant vertebral bone marrow lesions. Balliu E; Vilanova JC; Peláez I; Puig J; Remollo S; Barceló C; Barceló J; Pedraza S Eur J Radiol; 2009 Mar; 69(3):560-6. PubMed ID: 18276098 [TBL] [Abstract][Full Text] [Related]